Displaying 1–25 of 10809 results for

Sort By Relevance Sort By Date
1 2 3 4 5 ...433

Lannett to close Wyoming plant

(News)

Philadelphia-based Lannett announced it will close its Cody Laboratories subsidiary after failing to find a buyer.

Novartis' secret settlement for kickbacks revealed accidentally

(News)

Confidential settlement talks between Novartis and the U.S. government over allegations that the company paid doctors to market drugs were revealed when a letter written to U.S. District Judge was accidentally filed in the court docket.

Solid Dose: Under-hyped but not under-represented

(Article)

The buzz may be around biologics, but the oral solid dose sector is still going strong

JAMA study: Branded drug pricing trends

(News)

The Journal of the American Medical Association evaluated top-selling drugs finding that over a six year period, 78 percent of the drugs have seen an increase in costs by more than 50 percent.

Catalyst sues FDA for approving rival drug

(News)

The drama surrounding rival treatments for a rare autoimmune disease is mounting.

FDA slaps Indian manufacturer with an 10 observations

(News)

The FDA observations are piling up for one of India’s biggest generic drug manufacturers.

The future is transparent

(Article)

Supply Chain: The answer to today’s complexities lies in collaborative, sustainable supply chains.

FDA OKs Merck's Keytruda for head and neck cancer

(News)

The approval is based on a late-stage trial in which Keytruda showed a significant improvement in overall survival in cancer patients.

Roche names new CEO of $13B diagnostics unit

(News)

Thomas Schinecker is filling the shoes of the retiring Michael Heuer, who was holding the position on an interim basis.

Roche wins accelerated approval for cancer treatment

(News)

The FDA grants accelerated approval to Roche’s drug combo for lymphoma.

Experimental drug can delay onset of Type 1 diabetes

(News)

For the first time, researchers have shown that an immunotherapy can temporarily block the development a genetic disease.

Merck to buy Tilos Therapeutics

(News)

Merck & Co. announced it was buying privately held biopharmaceutical company, Tilos Therapeutics, in a deal that could be valued at up to $773 million.

Researchers look to

(News)

New trials have shown the drug psilocybin - the active ingredient of magic mushrooms - to be effective in treating depression, and U.S. cities are starting to decriminalize it.

INTERPHEX 2019: Still hip at forty

(Article)

INTERPHEX 2019 conference recap

Insys agrees to $225M opioid settlement

(News)

Insys Therapeutics has agreed to pay $225 million to settle the federal government's criminal and civil investigations into the company's marketing practices for it's fentanyl-based medication, Subsys.

Trump halts fetal-tissue research

(News)

The Trump administration announced that the federal government would sharply limit federal spending on medical research that uses tissue from aborted fetuses.

Lilly scores big win with expanded approval for migraine treatment

(News)

For the first time ever, the FDA has approved a medication to treat cluster headaches.

Report: Pfizer passed on promising Alzheimer’s research

(News)

A few years ago, researchers inside Pfizer reportedly discovered that one of the company’s blockbuster drugs could be a breakthrough treatment for Alzheimer’s.

Bayer partners with Arvinas in $750M biotech deal

(News)

The German drugmaker will be providing an upfront payment, pharmaceutical R&D support and an investment $60 million.

FDA expands Merck antibiotic indication to pneumonia treatment

(News)

The previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years and older.

How to boost your chances of winning an FDA drug approval

(Article)

The commercialization of a new drug follows a rigid path and applying for FDA approval can be a minefield of challenges. Here are expert tips for nailing your application.

Instrumental in profitability

(Article)

Automation: Reaping the benefits from improved instrument verification and calibration procedures.

Experimental Amgen drug gets positive results in cancer trial

(News)

A treatment that targets a specific genetic mutation has proven to be effective in shrinking tumors in some patients with advanced lung cancer.

FDA hearing on CBD raises more questions than answers

(News)

On Friday, the FDA listened to testimonies from over 100 stakeholders in the growing market for CBD, a non-psychoactive compound found in marijuana.

Gilead rolls out new CAR-T data at ASCO

(News)

Gilead's Kite announced findings from new analyses of CAR-T treatments at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.

Sort By Relevance Sort By Date
1 2 3 4 5 ...433